Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Integrated Sciences Inc
(NQ:
NVOS
)
0.6272
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Novo Integrated Sciences Inc
< Previous
1
2
3
Next >
Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC
March 23, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest
March 16, 2022
From
Novo Integrated Sciences, Inc. Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada
February 18, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports First Quarter Financial Results
January 18, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
January 14, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
December 23, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results
December 14, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient
November 30, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform
October 14, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)
October 04, 2021
Via
Get News
Novo Integrated Sciences to Present at the Benzinga Virtual Global Healthcare Small Cap Conference on September 30th
September 23, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States
August 30, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutrition to Manufacture and Distribute in the Middle East
August 18, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Third Quarter 2021 Financial Results
July 14, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer
July 07, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia
June 29, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc.
June 03, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC
May 26, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire PRO-DIP, LLC
May 17, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Formation of Medical Advisory Board
April 22, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Closing of $8 Million Registered Direct Offering
April 15, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Second Quarter 2021 Financial Results
April 14, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering
April 09, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.